Helus Pharma Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
8.96
+0.57 (6.79%)
At close: Nov 6, 2026, 4:00 PM EST
9.11
+0.14 (1.62%)
After-hours: Nov 6, 2026, 7:45 PM EST
Helus Pharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
100
Market Cap
654.62M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | - | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Geron | 217.52M |
| 4D Molecular Therapeutics | 92.01M |
| Kura Oncology | 77.23M |
| Wave Life Sciences | 70.92M |
| Adlai Nortye Group | 18.06M |
HELP News
- 5 days ago - Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference - GlobeNewsWire
- 12 days ago - Helus Pharma co-founders step down from executive roles, Lawson named chair - TheFly
- 12 days ago - Helus Pharma Announces Co-Founders' Transition from Executive Leadership as Company Advances Toward Next Stage of Development - GlobeNewsWire
- 18 days ago - Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026 - GlobeNewsWire
- 18 days ago - Helus Pharma Transcript: Study update - Transcripts
- 18 days ago - Helus Pharma Press release: Study update - Filings
- 18 days ago - Helus Pharma Slides: Study update - Filings
- 24 days ago - Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors - GlobeNewsWire